Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assial - Anti Tnf Treatment In Ankylosing Spondylitis: An Observational Cohort Study In Italy

NCT01856569 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01856569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01856569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assial - Anti Tnf Treatment In Ankylosing Spondylitis: An Observational Cohort Study In Italy
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
July 31, 2013
Completion date
November 30, 2015
Enrollment
152 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis